<?xml version="1.0" encoding="UTF-8"?>
<p id="p0210">
 <xref rid="bib27" ref-type="bibr">Coronavirus</xref>s, known for causing SARS and MERS epidemics, lead to another pandemic (COVID-19) having origin from Wuhan, China (
 <xref rid="bib14" ref-type="bibr">Chan et al., 2020</xref>). Like other coronaviruses, SARS-CoV-2 is also having an animal origin and is thought to be a result of the human-animal interface (
 <xref rid="bib72" ref-type="bibr">Lake, 2020</xref>; 
 <xref rid="bib165" ref-type="bibr">Zhu et al., 2020</xref>). Currently, 215 countries and territories are affected by about 10.71 million infected individuals and an approximate death toll of 0.51 million (
 <xref rid="bib109" ref-type="bibr">Organization, 2020b</xref>). Despite various preventive measures practiced all over the globe, the situation continues to worsen (
 <xref rid="bib25" ref-type="bibr">Columbus et al., 2020</xref>). The need for the day is to develop some therapeutics that may help to control and containing the pandemic. Research on viral epidemiology, the efficacy of various agents against the virus, and launching clinical trials on hospitalized patients are being carried at a rapid pace. Although no proven effective drug therapy is available to date, every day, some new aspects of viral epidemiology get unveiled, thereby unveiling the possible drug targets (
 <xref rid="bib25" ref-type="bibr">Columbus et al., 2020</xref>).
</p>
